Myomo (MYO) Change in Accured Expenses (2016 - 2025)
Myomo (MYO) reported Change in Accured Expenses of -$1.4 million for Q3 2025, down 251.21% on a YoY basis from $904822.0 in Q3 2024, and up 30.62% quarter-over-quarter from -$2.0 million in Q2 2025.
Myomo (MYO) Change in Accured Expenses (2016 - 2025) Analysis & Trends
Myomo has reported Change in Accured Expenses for 10 years, with the latest figure at -$1.4 million in Q3 2025.
- For the quarter ending Q3 2025, Change in Accured Expenses fell 251.21% year-over-year to -$1.4 million; the trailing twelve-month figure through Sep 2025 stood at $897995.0 (down 41.84% YoY), and the FY2024 full-year result was $4.7 million, up 162.17% from the prior year.
- Change in Accured Expenses for Q3 2025 stood at -$1.4 million, up from -$2.0 million in the prior quarter.
- The five-year high for Change in Accured Expenses was $2.8 million in Q4 2024, with the low at -$2.0 million in Q2 2025.
- Historically, Change in Accured Expenses has averaged $276958.9 across 5 years, with a median of $340854.0 in 2022.
- Annual changes were most pronounced in 2022 — Change in Accured Expenses jumped 6458.16% — and 2025, when it sank 318.16%.
- Myomo's Change in Accured Expenses stood at $535997.0 in 2021, then tumbled by 183.53% to -$447716.0 in 2022, then gained by 21.41% to -$351845.0 in 2023, then soared by 895.05% to $2.8 million in 2024, then slumped by 148.91% to -$1.4 million in 2025.
- The last three Change in Accured Expenses figures came in at -$1.4 million (Q3 2025), -$2.0 million (Q2 2025), and $1.4 million (Q1 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Accured Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.92 Bn | 146.27 Bn | 6.27 Bn | - |
| 2 | Stryker | 119.50 Bn | 116.62 Bn | 3.81 Bn | -654.00 Mn |
| 3 | Medtronic | 102.71 Bn | 94.54 Bn | 5.76 Bn | 703.00 Mn |
| 4 | Boston Scientific | 69.72 Bn | 68.51 Bn | 3.61 Bn | -512.00 Mn |
| 5 | Edwards Lifesciences | 49.24 Bn | 45.57 Bn | 1.29 Bn | -347.10 Mn |
| 6 | GE HealthCare Technologies | 29.74 Bn | 27.67 Bn | 1.98 Bn | -250.00 Mn |
| 7 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 21.07 Mn |
| 8 | Dexcom | 28.96 Bn | 27.84 Bn | 750.30 Mn | 145.10 Mn |
| 9 | Steris | 20.31 Bn | 19.88 Bn | 697.10 Mn | 74.30 Mn |
| 10 | Myomo | 45.01 Mn | 26.62 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -1.37 Mn |
| Sep 30, 2025 | -1.37 Mn |
| Jun 30, 2025 | -1.97 Mn |
| Jun 30, 2025 | -1.97 Mn |
| Mar 31, 2025 | 1.44 Mn |
| Mar 31, 2025 | 1.44 Mn |
| Dec 31, 2024 | 2.80 Mn |
| Dec 31, 2024 | 2.80 Mn |
| Sep 30, 2024 | 904,822.00 |
| Sep 30, 2024 | 904,822.00 |
| Jun 30, 2024 | 903,932.00 |
| Jun 30, 2024 | 903,932.00 |
| Mar 31, 2024 | 87,041.00 |
| Mar 31, 2024 | 87,041.00 |
| Dec 31, 2023 | -351,845.00 |
| Dec 31, 2023 | -351,845.00 |
| Sep 30, 2023 | 1.25 Mn |
| Sep 30, 2023 | 1.25 Mn |
| Jun 30, 2023 | 501,714.00 |
| Jun 30, 2023 | 501,714.00 |